PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32539736-13	2020	OXA administration upregulated p-CaMKKbeta, p-AMPK, and anti-inflammatory cytokines while downregulated p-NFkappaB and pro-inflammatory cytokines after ICH; this effect was reversed by STO-609 or JNJ-10397049 but not SB-334867.	2-phenyloxazolone	0-3	calcium/calmodulin-dependent protein kinase kinase 2, beta	Mus musculus	33-42	
32539736-14	2020	CONCLUSIONS: OXA improved neurofunctional outcomes and mitigated brain edema after ICH, possibly through alleviating neuroinflammation via OXR2/CaMKKbeta/AMPK pathway.	2-phenyloxazolone	13-16	calcium/calmodulin-dependent protein kinase kinase 2, beta	Mus musculus	144-153